In line with this, blood glucose levels, a reliable marker for insulin-producing tumor cell burden, was stable over the first treatment weeks, but continuously decreased in non-irradiated RIP1-Tag2 mice (Figure 1C). This evidence concerns the gene INS and neoplasm.